NurExone Biologic Inc. and BioXtek Inc. are advancing extracellular vesicles manufacturing, focusing on scalable GMP production of MSC-derived exosomes for regenerative therapies...
Read More »NurExone Biologic Inc. and BioXtek Inc. are advancing extracellular vesicles manufacturing, focusing on scalable GMP production of MSC-derived exosomes for regenerative therapies...
Read More »